Natera, Inc.·4

May 5, 9:45 PM ET

Brophy Michael Burkes 4

4 · Natera, Inc. · Filed May 5, 2026

Research Summary

AI-generated summary of this filing

Updated

Natera CFO Michael Brophy Sells 795 Shares

What Happened

  • Brophy Michael Burkes (listed as Natera's Chief Financial Officer) sold a total of 795 NTRA shares in two open‑market transactions: 313 shares on 2026‑05‑01 at $206.16 ($64,528) and 482 shares on 2026‑05‑04 at $210.49 ($101,456), for aggregate proceeds of $165,984. These were sales (not purchases).

Key Details

  • Transaction dates & prices: 2026‑05‑01 — 313 sh @ $206.16; 2026‑05‑04 — 482 sh @ $210.49.
  • Total sold: 795 shares for ~$165,984.
  • Shares owned after the transactions: not provided in the supplied Form 4 details.
  • Footnotes: sales were effected to satisfy tax withholding related to RSU vesting and were made pursuant to written instructions intended to meet Rule 10b5‑1(c) affirmative‑defense conditions (Stock Unit Agreement dated Jan 31, 2025). The sales were also effected under a Rule 10b5‑1 trading plan adopted June 9, 2025 and modified Sept 10, 2025.
  • Filing timeliness: Form 4 filed on May 5, 2026 (transactions occurred May 1 and May 4); filing appears timely (Form 4 is generally due within two business days).

Context

  • These were routine sell transactions to cover tax withholding on vested RSUs and were executed under a pre‑arranged 10b5‑1 plan. Such sales are typically administrative and do not necessarily signal a change in the insider’s view of the company. Purchases tend to be more informative about insider conviction.

Insider Transaction Report

Form 4
Period: 2026-05-01
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Transactions
  • Sale

    Common Stock

    [F1]
    2026-05-01$206.16/sh313$64,52857,978 total
  • Sale

    Common Stock

    [F2]
    2026-05-04$210.49/sh482$101,45657,496 total
Footnotes (2)
  • [F1]The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-05-05

Documents

1 file
  • 4
    form4-05052026_090501.xmlPrimary